noscript

News and Announcements

Cure Brain Cancer introduces SW/TCH Australia

  • Published October 29, 2014 10:12AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Cure Brain Cancer is excited to introduce SWITCH, an event which will bring young entrepreneurs, starts-ups, and ASX corporations together to solve big business challenges, while supporting brain cancer research.

SW/TCH Australia

Cure Brain Cancer is doing things differently to solve the complex problem of brain cancer and this week we are excited to announce another innovative initiative, SWITCH.

SWITCH is an innovation challenge held in Sydney and Melbourne over one weekend in March 2015, which will bring together young entrepreneurs, start-ups and ASX corporations to solve bold business challenges and design disruptive solutions. How will this benefit brain cancer research? Because all funds raised from this dynamic initiative will go towards Cure Brain Cancer.

Everybody wins; the corporations are introduced to fresh, young talent to achieve solutions for their biggest business problems, young entrepreneurs are introduced to business leaders, with the winner getting a trip to Silicon Valley, and all this raises much-needed funds for brain cancer research.

We are thrilled to be partnering with 650 Labs from Silicon Valley, who have co-designed SWITCH. Silicon Valley is the industry disruption capital of the world and our partnership with 650 Labs is an example of our shared philosophy, which recognises the need to challenge the status quo, embrace new thinking and be disruptive to achieve more agile outcomes for brain cancer patients.

At the breakfast launch event at Parliament House in Sydney, we were joined by some leading business figures, from the likes of Google, ANZ, Westfield, Salesforce, Oracle, Microsoft, Astra Zeneca and PwC. The launch featured keynote speeches by Mark Zawacki from 650 Labs and Cure Brain Cancer founder A/Prof Charlie Teo.

650 Labs’ Mark Zawacki says:

“Through this partnership we have co-designed SWITCH, bringing young entrepreneurs, start-ups and corporations together to solve big problems and benefit a big cause. Over one weekend in early 2015, these young entrepreneurs will be challenged to design disruptive business solutions across industries, resulting in a Silicon Valley prototype event.”

Cure Brain Cancer CEO Catherine Stace says:

“From day one at the launch, SWITCH has grabbed people’s attention. Business leaders are very interested to see an NFP doing things differently and coming up with innovative ideas to tackle the complex problem that is brain cancer. Our mission is to increase five-year survival to 50% within 10 years, and we are taking bold strides, thinking differently and being disruptive to make that happen.”

If you would like to learn more about taking part in SWITCH click here or contact [email protected].

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now